Literature DB >> 8006014

Background Ca2+ influx mediated by a dihydropyridine- and voltage-insensitive channel in pancreatic beta-cells. Modulation by Ni2+, diphenylamine-2-carboxylate, and glucose metabolism.

A M Silva1, L M Rosário, R M Santos.   

Abstract

A stepwise increase in extracellular Ca2+ concentration ([Ca2+]o) can evoke insulin release from pancreatic islets in the absence of secretagogues. We have investigated the ionic mechanism underlying this secretory response by recording intracellular free Ca2+ concentration ([Ca2+]i) from single mouse islets of Langerhans using ratiometric fura-2 microfluorometry. In the presence of 11 mM glucose, the [Ca2+]i undergoes fast oscillations associated with bursting electrical activity. Nifedipine (10 microM) suppressed these oscillations and markedly lowered the [Ca2+]i. Raising the [Ca2+]o from 2.56 to 12.8 mM in the continued presence of 11 mM glucose and nifedipine evoked pronounced [Ca2+]i rises of variable amplitude and time course. This effect was dose-dependent (EC50 = 3.6 mM) and remained essentially unchanged in the absence of glucose or in the presence of 3 mM glucose and nifedipine, conditions where beta-cells are hyperpolarized by approximately -25 mV. Depleting the acetylcholine-mobilizable internal Ca2+ pools by repetitively challenging the islets with acetylcholine in the absence of Ca2+ actually potentiated the standard high Ca2+ responses. The latter were strongly reduced by millimolar concentrations of Ni2+ (70% reduction at 3 mM) and by diphenylamine-2-carboxylate (DPC; IC50 = 145 microM), a blocker of nonselective cation channels. The standard high Ca2+ responses were relatively insensitive to the glycolytic inhibitor mannoheptulose. It is proposed that the high Ca(2+)-evoked [Ca2+]i responses are primarily accounted for by Ca2+ influx through dihydropyridine- and voltage-insensitive, nonselective cation channels. These channels do not appear to be under the control of glucose metabolism. Although their function is unknown, they may be essential to supplying the beta-cells with Ca2+ in the absence of stimulatory levels of fuel secretagogues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006014

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Localized calcium influx in pancreatic beta-cells: its significance for Ca2+-dependent insulin secretion from the islets of Langerhans.

Authors:  L S Satin
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

2.  A role for calcium release-activated current (CRAC) in cholinergic modulation of electrical activity in pancreatic beta-cells.

Authors:  R Bertram; P Smolen; A Sherman; D Mears; I Atwater; F Martin; B Soria
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

3.  Ca2+ entry into PC12 cells initiated by ryanodine receptors or inositol 1,4,5-trisphosphate receptors.

Authors:  D L Bennett; M D Bootman; M J Berridge; T R Cheek
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

4.  Magnitude and modulation of pancreatic beta-cell gap junction electrical conductance in situ.

Authors:  D Mears; N F Sheppard; I Atwater; E Rojas
Journal:  J Membr Biol       Date:  1995-07       Impact factor: 1.843

5.  Apoptosis in insulin-secreting cells. Evidence for the role of intracellular Ca2+ stores and arachidonic acid metabolism.

Authors:  Y P Zhou; D Teng; F Dralyuk; D Ostrega; M W Roe; L Philipson; K S Polonsky
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

6.  Control of pulsatile 5-HT/insulin secretion from single mouse pancreatic islets by intracellular calcium dynamics.

Authors:  R M Barbosa; A M Silva; A R Tomé; J A Stamford; R M Santos; L M Rosário
Journal:  J Physiol       Date:  1998-07-01       Impact factor: 5.182

7.  Insulin-like growth factors (IGF) I and II utilize different calcium signaling pathways in a primary human parathyroid cell culture model.

Authors:  C K M Wong; T Lai; J M P Holly; M H Wheeler; C E H Stewart; J R Farndon
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

Review 8.  Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II.

Authors:  Raquel Vieira; Selma B Souto; Elena Sánchez-López; Ana López Machado; Patricia Severino; Sajan Jose; Antonello Santini; Amelia M Silva; Ana Fortuna; Maria Luisa García; Eliana B Souto
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.